ausEE Inc. supports research by advising our members about current clinical trials they may be eligible to participate in through communications in our member/supporter newsletter, social media and here on our website. We know of several pipeline treatments in development and under clinical trial and share about their progress as trial data is reported through our social media pages and newsletter.
Clinical trials help researchers learn about treatments and enable participants the opportunity to access new treatments, contribute to medical research and take an active role in their healthcare. Trials and studies may include drug therapy and delivery, diagnosis and disease monitoring methods, dietary investigations and patient surveys.
Clinical trials help researchers learn about treatments and enable participants the opportunity to access new treatments, contribute to medical research and take an active role in their healthcare. Trials and studies may include drug therapy and delivery, diagnosis and disease monitoring methods, dietary investigations and patient surveys.
Open Clinical Trials
Eupraxia Pharmaceuticals Clinical Study
Having trouble swallowing or drinking?
Eosinophilic oesophagitis (EoE) can make swallowing food or drinks difficult and uncomfortable, sometimes causing food to feel stuck while eating.
This condition can interfere with everyday activities like meals, social situations, and daily routines.
Eupraxia Pharmaceuticals is conducting a clinical research study to evaluate an investigational treatment for adults with active EoE.
Participation criteria:- Adults 18 to 75 years old- Diagnosed with eosinophilic oesophagitis (EoE)- Currently experiencing active EoE symptoms Why participate?- Access to an investigational treatment being studied for EoE- Study visits conducted by experienced research clinicians- No cost to participate- Opportunity to contribute to research focused on improving EoE care
This condition can interfere with everyday activities like meals, social situations, and daily routines.
Eupraxia Pharmaceuticals is conducting a clinical research study to evaluate an investigational treatment for adults with active EoE.
Participation criteria:- Adults 18 to 75 years old- Diagnosed with eosinophilic oesophagitis (EoE)- Currently experiencing active EoE symptoms Why participate?- Access to an investigational treatment being studied for EoE- Study visits conducted by experienced research clinicians- No cost to participate- Opportunity to contribute to research focused on improving EoE care
A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE). (RESOLVE). ClinicalTrials.gov ID: NCT05608681
This clinical trial is being run at several sites in Australia and New Zealand. To learn more about this study, please contact the study location by email.
QueenslandDr Holtmann - Princess Alexandra Hospital, Brisbane - Teressa.Hansen@health.qld.gov.auDr Seltenreich - Coastal Digestive Health, Sunshine Coast - KateSara@cdhresearch.com.au
New South WalesDr Ho - Sydney Clinical Trials, Sydney - admin@sydneyclinicaltrials.com.au
VictoriaDr Burgell - The Alfred, Melbourne - jean.zhang@alfred.org.auDr Garg - Northern Hospital, Melbourne - Ashleigh.Smallman@nh.org.auDr Hannah - Royal Melbourne Hospital, Melbourne - nicola.dalgleish2@mh.org.auDr Nandurkar - Box Hill Hospital (Eastern Health), Melbourne - emma.dimitri@monash.edu
South AustraliaDr Nguyen - Royal Adelaide Hospital, Adelaide - Joshua.Zobel@sa.gov.au Dr Philpott – Lyell McEwin Hospital, Adelaide - Rity.Wong@sa.gov.au Perth Dr Lim – St John of God Midland Public Hospital, Perth - MI.clinicaltrials@sjog.org.au
New ZealandDr Inns - Capital, Coast and Hutt Valley, Wellington - ana.enriquez@ccdhb.org.nzDr Lim - Aotearoa Clinical Trials, Auckland - ethan.chiddicks@aotearoatrials.nzDr Weilert - Waikato Gastroenterology Clinical Trials, Waikato - Heather.logan@waikatodhb.health.nz
New South WalesDr Ho - Sydney Clinical Trials, Sydney - admin@sydneyclinicaltrials.com.au
VictoriaDr Burgell - The Alfred, Melbourne - jean.zhang@alfred.org.auDr Garg - Northern Hospital, Melbourne - Ashleigh.Smallman@nh.org.auDr Hannah - Royal Melbourne Hospital, Melbourne - nicola.dalgleish2@mh.org.auDr Nandurkar - Box Hill Hospital (Eastern Health), Melbourne - emma.dimitri@monash.edu
South AustraliaDr Nguyen - Royal Adelaide Hospital, Adelaide - Joshua.Zobel@sa.gov.au Dr Philpott – Lyell McEwin Hospital, Adelaide - Rity.Wong@sa.gov.au Perth Dr Lim – St John of God Midland Public Hospital, Perth - MI.clinicaltrials@sjog.org.au
New ZealandDr Inns - Capital, Coast and Hutt Valley, Wellington - ana.enriquez@ccdhb.org.nzDr Lim - Aotearoa Clinical Trials, Auckland - ethan.chiddicks@aotearoatrials.nzDr Weilert - Waikato Gastroenterology Clinical Trials, Waikato - Heather.logan@waikatodhb.health.nz
Eosinophilic Oesophagitis Study
Griffith University are examining the effect of a new treatment in helping to reduce symptoms of eosinophilic oesophagitis. The trial is looking for adults across Australia and involves taking a new gel-based supplement for 12 weeks and monitoring your symptoms. By taking part you will have the opportunity to be involved in the latest research for eosinophilic oesophagitis.
Please contact Rebecca at immunology-research@griffith.edu.au or 0422 381 424 for further information.
Other opportunities to participate in research
EGID Partners
EGID Partners is an online cohort of patients with eosinophilic gastrointestinal diseases (EGIDs) brought to you in a collaboration between Patient Advocacy Groups and Researchers.
EGID Partners engages patients to help guide research. People without EGIDs are also encouraged to join so data can be compared. Together we can advance the care of conditions like eosinophilic esophagitis (EoE), eosinophilic gastritis (EoG), and eosinophilic colitis (EoC). ausEE Inc. is proud to be a patient advocacy group partner of EGID Partners.
Visit egidpartners.org to learn more and to become a Partner!
EGID Partners engages patients to help guide research. People without EGIDs are also encouraged to join so data can be compared. Together we can advance the care of conditions like eosinophilic esophagitis (EoE), eosinophilic gastritis (EoG), and eosinophilic colitis (EoC). ausEE Inc. is proud to be a patient advocacy group partner of EGID Partners.
Visit egidpartners.org to learn more and to become a Partner!
Rare Patient Voice
Are you a patient or family caregiver with something to say?
Make your voice heard by participating in paid surveys, interviews and online communities!
Start talking to the right people. It's free!
ausEE Inc. is a referral partner of Rare Patient Voice and we will receive a $10 contribution for every eligible person who signs up through this referral link.
